The treatment of primary immune thrombocytopenia from the perspective of spleen blood deficiency: a case report

Abstract

Background

Primary immune thrombocytopenia (pITP) is caused by the increase of platelet destruction and decrease of platelet production mediated by immune disorders. The specific pathogenesis of ITP is complicated and unclear, so the treatment of ITP is still under exploration in both Chinese and Western medicine.

Case presentation

A 56-year-old female patient with primary immune thrombocytopenia (ITP) achieved normalization of platelet levels following a 4-month course of combined Chinese and Western medical treatment. During the gradual reduction of both Chinese and Western medications over these 4 months, the patient's condition remained stable, with the goal of eventually discontinuing treatment.

Conclusion

Our case demonstrates that TCM therapy targeting spleen blood deficiency can achieve favorable therapeutic outcomes in ITP, thereby providing a novel treatment alternative for this condition.